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(diallyldimethylammonium) chloride 
in nanoparticles of poly (methylmethacrylate)
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Abstract 
Background: Several cationic polymers exhibit a useful antimicrobial property, however the structure–activity 
relationship still requires a more complete investigation. The main objective of this work is the comparison between 
the antimicrobial activity and toxicity of free and immobilized poly (diallyldimethylammonium) chloride (PDDA) in 
biocompatible poly (methylmethacrylate) (PMMA) nanoparticles (NPs).
Results: NPs synthesis by emulsion polymerization is performed over a range of [PDDA] at two methylmethacrylate 
(MMA) concentrations. The PMMA/PDDA dispersions are characterized by dynamic light‑scattering for sizing, poly‑
dispersity and zeta‑potential analysis, scanning electron microscopy (SEM), plating plus colony forming unities (CFU) 
counting for determination of the minimal microbicidal concentrations (MMC) against Escherichia coli, Staphylococ-
cus aureus and Candida albicans and hemolysis evaluation against mammalian erythrocytes. There is a high colloidal 
stability for the cationic PMMA/PDDA NPs over a range of [PDDA]. NPs diverse antimicrobial activity against the 
microorganisms reduces cell viability by eight‑logs (E. coli), seven‑logs (S. aureus) or two‑logs (C. albicans). The NPs 
completely kill E. coli over a range of [PDDA] that are innocuous to the erythrocytes. Free PDDA antimicrobial activity 
is higher than the one observed for PDDA in the NPs. There is no PDDA induced‑hemolysis at the MMC in contrast 
to the hemolytic effect of immobilized PDDA in the NPs. Hemolysis is higher than 15 % for immobilized PDDA at the 
MMC for S. aureus and C. albicans.
Conclusions: The mobility of the cationic antimicrobial polymer PDDA determines its access to the inner layers of 
the cell wall and the cell membrane, the major sites of PDDA antimicrobial action. PDDA freedom does matter for 
determining the antimicrobial activity at low PDDA concentrations and absence of hemolysis.
Keywords: Biocompatible polymer, Antimicrobial polymer, Antimicrobial nanoparticles, Poly (methylmethacrylate), 
Particle characterization by light scattering and scanning electron microscopy
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Background
The rise of multidrug resistant pathogens is one of 
the top three threats to global public health listed by 
the World Health Organization [1, 2]. The biomedical 
applications of synthetic, biodegradable polymers for 
the development of anti-infective strategies can over-
come instability, side effects, toxicity and frequent dose 
regimens of drugs [2]. A possible approach to obtain 
antimicrobial nanoparticles (NPs) involves polymers 
as carriers of the active substance or the polymer itself 
as the active substance [3]. Biocompatible and antimi-
crobial polymers are becoming the materials of choice 
for developing several novel structures of biomedical 
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importance against infectious diseases [3–7]. There are 
two established routes to produce polymeric systems 
with antimicrobial properties. The first assembles by 
physical interactions the active molecule in a polymer 
matrix, while the second involves covalent binding of the 
active substance in the polymer carrier [3]. Polycationic 
structures usually present high activity, due to mass and 
charge localization that promotes electrostatic interac-
tions between the cationic structure and the negatively 
charged bacterial cell membrane, resulting in disruption 
of the cell membrane and/or wall [8, 9]. Being environ-
ment friendly also plays in favor of the usage of quater-
nary ammonium compounds (QACs) [10]. QACs such as 
dioctadecyldimethylammonium bromide (DODAB) are 
miscible with some biocompatible polymers such as poly 
(methylmethacrylate) (PMMA) in spin-coated films, do 
not leak from the polymeric matrix and kill bacteria upon 
contact [11]. Cetyltrimethylammonium bromide (CTAB) 
is more mobile and leaks out from PMMA films killing 
bacteria in the bulk solution [12]. PMMA NPs containing 
CTAB or DODAB synthesized by emulsion polymeriza-
tion display high bactericidal activity [13]. For obtaining 
the PMMA NPs, emulsion polymerization involves two 
steps: nucleation and growth of the particles [14–18]. The 
available sites for polymerization are the monomer drop-
lets of the methylmetacrylate (MMA) in water dispersed 
as a microemulsion [19]. Slightly hydrophilic monomers 
such as MMA result in smaller droplets because MMA 
at the interface of polymerized particles acts as a co-
surfactant [20]. The free radicals generated by the initia-
tor can react with MMA in the micelles and inside the 
MMA monomer droplets in the aqueous phase, yield-
ing oligoradicals. As the chain length of the oligoradicals 
increases, they can diffuse into the micelle interior and/
or the monomer droplets to proceed with the polymeri-
zation [14]. Among the cationic antimicrobial polymers, 
poly (diallyldimethylammonium) chloride (PDDA) also 
exhibits the quaternary ammonium moiety as pendant 
groups in its chemical structure and displays outstanding 
antimicrobial activity [4, 21–23]. In this work, we syn-
thesize PMMA/PDDA NPs by surfactant-free emulsion 
polymerization of MMA in the presence of PDDA in 
order to determine the effect of PDDA immobilization on 
its activity against microorganisms or red blood cells.
Results
Preparation and characterization of PMMA/PDDA NPs
Emulsion polymerization of MMA in the presence of 
PDDA with azobisisobutyronitrile (AIBN) as the radi-
cal initiator is done under N2 flow in order to prevent 
the precocious termination of the free radicals required 
for the MMA addition reaction and the synthesis of the 
PMMA particles. Table 1 shows the main physical prop-
erties of the dispersions as a function of different feed 
concentrations of the MMA monomer or the cationic 
antimicrobial polymer amphiphile (PDDA). Formulations 
A3, A4, A5, B3, B4 and B5 yield cationic dispersions with 
high colloidal stability at PDDA concentrations of 3, 4 or 
5 mg/mL, respectively, at two different MMA concentra-
tions employed during the particle synthesis 0.56 (named 
A) or 1.32  M MMA (named B). Thus a formulation A3 
means that particle synthesis was carried out with 0.56 M 
MMA and 3  mg/mL PDDA whereas a formulation B4 
means that 1.32 M MMA and 4 mg/mL PDDA were used 
for particle’s synthesis. In general, for syntheses carried 
out in the presence of PDDA, the zeta-average diameter 
(Dz) or mean hydrodynamic diameter varied between 
230 and 328  nm while the zeta-potential (ζ) values var-
ied between 62 and 69 mV. All dispersions in Table 1 pre-
sent long-term colloidal stability. Precipitates or flocs do 
not occur for as long as 2 years. At [PDDA] <2 mg/mL, 
precipitation of PMMA/PDDA is visible. Thus the dis-
persions at and above 3 mg/mL of [PDDA] are stable and 
selected for further determination of antimicrobial activ-
ity. The incorporation of PDDA into the PMMA/PDDA 
NPs is shown from elemental analysis for nitrogen in the 
lyophilized dispersions (Table 1).
The effect of PDDA and MMA concentrations on the 
physical properties of the particles is in Table 1: Dz, ζ and 
the polydispersity (P) for the dispersions from dynamic 
light-scattering (DLS) were determined after exhaustive 
dialysis. In the case of formulations A3, A4, A5, B3, B4 and 
Table 1 Physico-chemical properties of PMMA/PDDA dispersions in aqueous medium at 1 mM NaCl
Characterization of PMMA/PDDA dispersions of high colloidal stability regarding particle size from DLS (Dz ± the mean standard deviation, SD) or from the SEM 
images (D ± the mean standard deviation), ζ values, P values, Mw, SC, Np and elemental analysis for percentiles (%) of C, H and N
NPs Dz ± SD (nm) D ± SD (nm) ζ (mV) P Mw (g/mol) SC (mg/mL) Np (mL−1) % C % H % N
A3 257 ± 2 127 ± 12 66 ± 2 0.06 ± 0.01 1,173,000 5.5 ± 0.4 4.33 × 1012 53.8 ± 0.6 8.6 ± 0.1 2.4 ± 0.3
A4 328 ± 2 112 ± 17 67 ± 1 0.03 ± 0.01 1,065,000 10.0 ± 0.7 1.15 × 1013 55.4 ± 0.5 8.6 ± 0.1 1.5 ± 0.2
A5 286 ± 2 164 ± 32 69 ± 4 0.02 ± 0.01 2,872,000 4.4 ± 0.2 1.62 × 1012 51.5 ± 0.0 9.0 ± 0.2 3.7 ± 0.1
B3 232 ± 1 151 ± 27 62 ± 2 0.07 ± 0.01 1,514,000 7.3 ± 0.4 3.46 × 1012 52.5 ± 0.0 8.8 ± 0.3 3.0 ± 0.3
B4 230 ± 1 139 ± 22 67 ± 2 0.04 ± 0.01 2,362,000 5.8 ± 0.4 3.47 × 1012 50.3 ± 0.0 9.2 ± 0.4 4.2 ± 0.4
B5 262 ± 1 143 ± 23 66 ± 2 0.08 ± 0.02 2,056,000 7.2 ± 0.1 3.99 × 1012 50.7 ± 0.2 9.3 ± 0.5 3.9 ± 0.3
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B5, the PDDA concentration is enough to give stability for 
the positively charged dispersions so that these are the for-
mulations selected for additional characterization. Determi-
nations of solid contents, conversion rate of monomer into 
polymer, particle number density (Np), average molecular 
weight (Mw) obtained by size exclusion chromatography 
(SEC), morphology of lyophilized particles from scanning 
electron microscopy (SEM), and antimicrobial activity 
against bacteria from plating and colony forming unities 
(CFU) counting were carried out. Table 1 shows also data 
on Np calculated from the mass of one particle (mp) taken as 
its volume (πrp3 4/3) times the PMMA density (1.15 × 103 g/
dm3) where the particle radius (rp) is half the particle diam-
eter (D) obtained by SEM. Since the solid content (SC) for 
each formulation is obtained by gravimetry in mg/mL and 
mp is known, the particle number density Np (the number of 
particles in 1 mL of dispersion) can be calculated (Table 1). 
The additional file 1 shows photographs (Additional file 1: 
Figure S1) and size distributions of NPs dispersions imme-
diately after dialysis and synthesis (Additional file 1: Figure 
S2) or after two years (Additional file 1: Figure S3) plus data 
on molecular weights and PDI obtained from SEC (Addi-
tional file 1: Table S1).
The PDDA concentration in 1  mL of each dispersion 
was determined from the solid contents (SC), in mg/
mL, and the % N determined by elemental analysis after 
lyophilization. One mole of PDDA contains 928.8 mono-
mers since diallyldimethylammonium choride (DDA) 
molecular weight is 161.5 g and PDDA molecular weight 
is 150,000 g. Thus 928.8 mol of N in one mole of PDDA 
yields 13003.2 g N per mole of PDDA. The nitrogen mass 
in the lyophilized samples is the SC × FN where FN is the 
mass fraction of nitrogen atoms (N) in 1 mL of each dis-
persion and the PDDA concentration is given by:
The PDDA concentration for all dispersions is sys-
tematically smaller than the one added for the particle 
synthesis (Table  2). A possible reason for this might be 
related to the fact that PDDA is cationic and can adsorb 
[PDDA](mg/ml) =
1.5× 105 × SC× FN
13003.2
onto the glass used for synthesis and also onto the cel-
lulose acetate membrane where dialysis was performed. 
Therefore, The PDDA concentration used during the 
particle synthesis cannot be considered the real one pre-
sent in the NPs. The incorporation of PDDA in the NPs is 
higher for the higher MMA concentrations used for par-
ticle synthesis (Table 2).
The effect of PDDA concentration on Dz, ζ and P of the 
PMMA/PDDA NPs is in Fig.  1. At [PDDA]  <2  mg/mL, 
the poor colloidal stability results in large sizes, precipita-
tion, low ζ and high P. At [PDDA] >2 mg/mL, small sizes, 
high positive ζ and low P mean a good colloidal stability 
for the selected dispersions (A3, A4, A5, B3, B4, B5).
There is no aging effect on the physical properties of 
the selected dispersions. PMMA/PDDA formulations 
stored in the lab bench for 12 months at room tempera-
ture do not evidence precipitation/aggregation, floccula-
tion, or apparent growth of microorganisms. The physical 
properties remain the same even 2  years after synthesis 
(Additional file 1: Figure S3).
Table 2 Determining PDDA concentration in the NPs
Calculation of PDDA concentration in the hybrid PMMA/PDDA NPs from SC and 
% N. FN is the mass fraction of nitrogen
Dispersion % N FN SC (mg/mL) [PDDA] (mg/mL)
A3 2.4 0.024 5.5 1.53
A4 1.5 0.015 10.1 1.74
A5 3.7 0.037 4.4 1.88
B3 3.0 0.030 7.3 2.52
B4 4.2 0.042 5.8 2.80
B5 3.9 0.039 7.2 3.24
b
a
c
Fig. 1 The dependence of physical properties of PMMA/PDDA NPs 
on PDDA concentration. a Dz as a function of PDDA concentration, b 
ζ as a function of PDDA concentration and, c P as a function of PDDA 
concentration, at two different MMA concentrations used for particle 
synthesis
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The NPs were also observed by SEM (Fig.  2). These 
images were submitted to the ImageJ software for deter-
mining D of the dried NPs (Table 1).
The effect of ionic strength on Dz of NPs for the A3 
dispersion is shown on Fig.  3. There is a reduction of 
Dz taking place as a function of the NaCl concentration 
in the NP medium. The Dz for A3 NPs decreases by ca. 
70–80  nm due to the addition of 100  mM NaCl to the 
NP medium. On Table  1, the comparison between Dz 
and D suggests an interesting drying effect on the NPs 
structure. Dz for the A3 dispersion is 257 nm whereas D 
(obtained after drying) is 127  nm, meaning a reduction 
of ca. 130 nm after drying (Figs. 2, 3; Table 1). Drying or 
increasing the ionic strength of the medium substantially 
reduces the NPs diameter.
Antimicrobial and hemolytic activity of PMMA/PDDA NPs
The NPs of high colloidal stability were tested against the 
Gram–negative E. coli (Fig. 4), Gram-positive S. aureus 
(Fig.  5) and the yeast C. albicans (Fig.  6) revealing the 
effect of PDDA alone or in the PMMA/PDDA NPs on 
the cell viability of these microorganisms. One should 
firstly notice the logarithmic scale for the CFU/mL 
counting which allows the perfect determination of the 
potency and effectiveness of the antimicrobials under 
testing. The other way of presenting cell viability data, 
A3 B3
A4 B4
A5 B5
0.3 μm 0.3 μm
0.3 μm 0.3 μm
0.3 μm 0.3 μm
Fig. 2 Morphology of PMMA/PDDA NPs from SEM micrographs. The dispersions A3, A4, A5, B3, B4 and B5 are seen under low and high magnifica‑
tion. The bar corresponds to 1 µm. The inserts show magnified images of the same dispersions
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the percentile of CFU/mL, does not allow discriminat-
ing between moderate and highly potent antimicrobial 
agents. A two-log decrease of cell viability already shows 
on the percentile plot as an apparent decrease of cell 
viability to practically zero. PDDA and NPs are highly 
effective against E. coli reducing cell viability to practi-
cally zero (Fig. 4).
However, against S. aureus, PDDA concentrations lead-
ing to the complete loss of cell viability were much higher 
than those determined against E. coli (Fig. 5).
Against the yeast C. albicans, free PDDA is effective to kill 
almost completely the fungus but PDDA immobilized in the 
NPs has a reduced activity (Fig. 6), suggesting an important 
role for the PDDA mobility to reach the cell sites of action 
such as the cell membrane and the cell wall. On the PMMA/
PDDA NPs, the PDDA link to the NP would hamper its 
mobility and thereby its activity against the fungus cells.
0 50 100
200
250
Dz (nm)
NaCl concentration (mM)
Fig. 3 The collapse of the outer PDDA layer on NPs. Dz for NPs (A3 
dispersion) is a function of NaCl concentration
0
2
4
6
8  NPs from A3
 PDDA
 NPs from B3
 PDDA
[PDDA] (mg/mL)
0
2
4
6
8  NPs from A4
 PDDA
 NPs from B4
 PDDA
10-4 10-3 10-2 10-1 100
0
2
4
6
8  NPs from A5
 PDDA
10-4 10-3 10-2 10-1 100
lo
g 
(C
FU
/m
L)
 NPs from B5
 PDDA
Fig. 4 Antimicrobial activity of NPs against E. coli. Cell viability (log CFU/mL) for E. coli at 3–6 × 107 CFU/mL as a function of PDDA concentration for 
free PDDA or PDDA in the PMMA/PDDA NPs diluted from dispersions A3, A4, A5, B3, B4 and B5. Cells and NPs or free PDDA interacted for 1 h before 
plating for CFU counting
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PDDA alone barely affects the red blood cells over the 
range of PDDA concentrations for which PDDA kills effi-
ciently the microorganisms (Fig. 7). However, with excep-
tion of the effect against E. coli, for PDDA in the NPs, the 
toxicity against the red blood cells is relevant over the 
same range of PDDA concentrations effective against the 
pathogenic microorganisms (Table 3).
Discussion
PMMA/PDDA NPs utility in vivo and ex vivo
The PMMA/PDDA NPs obtained by the one-pot syn-
thesis are surfactant-free and have several interesting 
properties: NPs are all of the same size, have high col-
loidal stability and exhibit antimicrobial properties. 
These are remarkable properties achieved by a simple 
procedure as is emulsion polymerization. This method 
can possibly be carried out also in the presence of other 
interesting antimicrobial compounds aiming at their 
immobilization in the polymeric nanoparticles. The 
painting, coating, food processing, air-conditioning or 
water-treatment industries usually welcome antimicro-
bials for several ex vivo applications. The particle synthe-
sis here described in the presence of PDDA can also be 
performed in the presence of other antimicrobial agents 
such as the Gemini surfactants [24–27], conjugated 
polyelectrolytes [28], polynorbornenes [29], lipopeptides 
[30], and hydrophobic drugs [31, 32], all of them rep-
resenting good candidates for incorporation in PMMA 
nanoparticles during their synthesis. However, the char-
acterization of the novel assemblies will have to be per-
formed for each novel compound in the PMMA matrix 
and their activity compared to the one of the free antimi-
crobial substance.
The collapse of the outer PDDA layer takes place 
upon drying or increasing the medium ionic strength
The reduction in NP size taking place as a function 
of the NaCl concentration is meaningful (Fig.  3). This 
result suggests that neutralization of PDDA posi-
tive charges by monovalent salt collapses the stiff, 
0
2
4
6
8  NPs from A3
 PDDA
 NPs from B3
 PDDA
0
2
4
6
8
lo
g 
(C
FU
/m
L)
 NPs from A4
 PDDA
 NPs from B4
 PDDA
10-4 10 -3 10 -2 10 -1 100
0
2
4
6
8  NPs from A5
 PDDA
10-4 10 -3 10 -2 10 -1 100
 NPs from B5
 PDDA
[PDDA] (mg/mL)
Fig. 5 Antimicrobial activity of NPs against S. aureus. Cell viability (log CFU/mL) for S. aureus at 4–9 × 107 CFU/mL as a function of PDDA concentra‑
tion for free PDDA or PDDA in the PMMA/PDDA NPs diluted from dispersions A3, A4, A5, B3, B4 and B5. Cells and NPs or free PDDA interacted for 1 h 
before plating for CFU counting
Page 7 of 13Sanches et al. J Nanobiotechnol  (2015) 13:58 
protruding PDDA charged chains reducing the shell 
thickness on NPs. The effect of salt possibly is very 
similar to the effect of drying on the NP structure. 
The PDDA protuberances mechanically bound to the 
PMMA NP core have their charge screened by salt and 
their collapse amounts to a 80 nm reduction in particle 
size confirming the core–shell nature of the NPs struc-
ture, with PMMA residing in the core and PDDA occu-
pying the shell. For any charged surface, the extent of 
the double layer thickness decreases with the electro-
lyte concentration, due to osmotic effects. For instance, 
for 10−5 M NaCl it is 100  nm, for 10−3 M NaCl it is 
10  nm and for 10−1 M NaCl it is 1  nm. Additionally, 
the persistence length of a polyelectrolyte, such as 
PDDA, decreases as the ionic strength increases [33], 
so that at 1  mM NaCl the PDDA chains are stiff due 
to electrostatic repulsion among the segments, while at 
100 mM NaCl the PDDA charges are screened and the 
chains behave like collapsed coils. Figure  8 illustrates 
the structure of the NPs suggested by the experiment 
shown in Fig. 3.
The antimicrobial activity of PMMA/PDDA NPs depends 
on the microorganism and the hydrophobic–hydrophilic 
balance of the cationic polymer
The diverse antimicrobial effect of PMMA/PDDA NPs 
reducing eight-, seven- and two-logs of viable E. coli, S. 
aureus and C. albicans cells may be related to the dif-
ferences in the microbial cell wall structures. A sensor 
system in Staphylococcus sp. is able to counteract the 
action of cationic antimicrobial compounds [34]. When 
these Gram-positive bacteria cells enter in contact with 
cationic compounds, the D-alanylation of teichoic acids 
and the lysylation of phosphatidylglycerol decrease the 
negative charge of the cell surface and membrane thereby 
hampering the adsorption of the cationic antimicrobials 
[34]. This might explain the relatively lower activity of 
the NPs against S. aureus (Fig. 5) when compared to the 
one against E. coli (Fig. 4). For the yeast cells, the antimi-
crobial compound has also to penetrate through the cell 
wall reaching the yeast cell membrane to exert fungicidal 
activity. The molecular architecture of the cell wall of C. 
albicans consists of an inner skeletal layer composed of 
0
2
4
6  NPs from A3
 PDDA
lo
g 
(C
FU
/m
L)
 NPs from B3
 PDDA
[PDDA] (mg/mL)
0
2
4
6  NPs from A4
 PDDA
 NPs from B4
 PDDA
10 -4 10 -3 10 -2 10 -1 10 0
0
2
4
6  NPs from A5
 PDDA
10 -4 10 -3 10 -2 10 -1 10 0
 NPs from B5
 PDDA
Fig. 6 Antimicrobial activity of NPs against C. albicans. Cell viability (log CFU/mL) for C. albicans at 4–5 × 105 CFU/mL as a function of PDDA con‑
centration for free PDDA or PDDA in the PMMA/PDDA NPs diluted from dispersions A3, A4, A5, B3, B4 and B5. Cells and NPs or free PDDA interacted 
for 1 h before plating for CFU counting
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the stress-bearing polysaccharides β-1,3-glucan and chi-
tin, which run parallel to the cell surface [23]. The inner 
layer is kept together by extensive hydrogen bonding 
between individual β-1,3-glucan chains and by the β-1,3-
glucan by a cross-linking protein. This three-dimensional 
skeletal network acts as a scaffold for a dense outer layer 
of glycoproteins extending into the environment forming 
like a brush layer. Our results suggest that the spherical 
cationic NPs would not be able to penetrate the brush 
layer yielding poor fungicidal activity for PMMA/PDDA 
NPs in comparison to the excellent activity of free PDDA, 
which can penetrate the brush layer unhindered due to its 
needle-like structure (Fig. 6). In fact, this result is consist-
ent with previous data for PDDA as the outermost layer 
of self-assembled NPs in which PDDA motility to pen-
etrate the cells is not restricted and the polymer can dis-
assemble easily from the NP to penetrate the cell [35]. A 
good example that the mobility of the antimicrobial qua-
ternary ammonium moiety indeed matters can be found 
in the dentistry field, where resins have been grafted with 
pendant and permanent quaternary ammonium groups 
[36]. Grafting of a quaternary ammonium antimicrobial 
component in the resin network can be achieved through 
copolymerization of the antimicrobial monomers with 
0
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[PDDA] (mg/mL)
 NPs from B3
 PDDA
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Fig. 7 Toxicity of NPs against mammalian red blood cells. Hemolysis (%) as a function of PDDA concentration for free PDDA or PDDA in the PMMA/
PDDA NPs diluted from dispersions A3, A4, A5, B3, B4 and B5. Red blood cells and NPs or PDDA interacted for 1 h before determining % hemolysis
Table 3 Antimicrobial and hemolytical activities of PMMA/
PDDA NPs
MMC, in mg mL−1 , and hemolysis percentiles in between parentheses (% H) at 
the MMC for free PDDA or in the PDDA/PMMA NPs
a For PDDA against C. albicans, MMC is the smallest [PDDA] leading to a five-log 
reduction of cell viability
Dispersion MMC (% H)
E. coli S. aureus C. albicans
PDDA 0.005 (0) >0.5 (0) 0.005 (0)a
A3 0.007 (0) 0.1 (15) >0.8 (>63)
A4 0.007 (0) 0.5 (20) >0.8 (>33)
A5 0.007 (0) 0.5 (48) >1.0 (>75)
B3 0.010 (0) 0.6 (23) >1.0 (>41)
B4 0.003 (0) 0.8 (65) >1.5 (>90)
B5 0.003 (0) 0.8 (48) >1.5 (>83)
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the conventional methacrylate monomers [36]. While 
free, non -polymerized quaternary ammonium mono-
mers can rapidly kill oral pathogens, the antimicrobial 
component immobilized by poly-merization does not 
exhibit equally strong inhibitory effects [36].
For self-assembled NPs built from oppositely charged 
layers of cationic bilayer fragments, anionic polyelectrolyte 
and PDDA, the interaction of the outer PDDA layer with 
elements of the cell wall induce withdrawal of major com-
ponents of the cell wall and membrane disruption culmi-
nating in leakage of intracellular components and microbe 
death [35]. Thus, freedom of the antimicrobial polymer to 
interact with the microbial cell is indeed very important.
The incorporation of antimicrobial surfactants or lipids 
in PMMA particles [13] or coatings [11, 12] during the 
PMMA synthesis by emulsion polymerization would 
represent a simple and inexpensive way of obtaining bio-
compatible antimicrobial materials. However, the con-
struction of the PMMA/PDDA NPs with PDDA as the 
shell and PMMA as the core diminished the advantages 
of using PMMA as the biocompatible polymer (Figs.  3, 
8). PDDA location in the NP shell leaves the antimicro-
bial toxic NP moiety as the outermost NP shell. Toxic-
ity against the red blood cells becomes high as often 
described for cationic NPs and dendrimers [37]. The fact 
that free PDDA barely affects the viability of red blood 
cells (Fig. 7) is in agreement with previous work [23] and 
can be understood from simple adsorption of the PDDA 
macromolecule onto the red blood cell surface without 
penetration in the cell membrane. On the other hand, 
when compared with the free PDDA, the PMMA/PDDA 
NPs showed an increased ability to penetrate into the 
red blood cells disturbing the cell membrane and caus-
ing its lysis (Fig.  7). Previously described self-assembled 
NPs with PDDA as the outermost adsorbed layer are not 
hemolytic over the range of concentrations required to 
kill the microorganisms [23]. For the PMMA/PDDA NPs 
described in this work, this occurs only for E. coli (Fig. 4). 
For the other microorganisms, the relatively high micro-
bicidal PDDA concentrations in the NPs belong to the 
same range of concentrations where hemolysis becomes 
significant (Table 3). When the cationic antimicrobial self-
assembled NPs [21, 22] enter in contact with oppositely 
charged cells, we have recently shown that they disassem-
ble and release PDDA to act as a free compound [35].
In vivo liposomes, particles and bacteria are engulfed 
by the phagocytic cells [38] so that their co-localization 
allows optimal activity for particle-based formulations 
against the microbes. The tests performed in  vitro cer-
tainly cannot predict the efficacy of the in vivo PMMA/
PDDA antimicrobial particles and further testing should 
be performed in animal models of infection.
Data on antimicrobial activity of some PDDA deriva-
tives were previously reported by Timofeeva and cowork-
ers [39]. These PDDA derivatives have none, one or two 
methyls on the nitrogen as shown in Fig. 9 for as poly (dial-
lylammonium trifluoroacetate) (PDAATFA), poly (diallyl-
methylammonium trifluoroacetate) (PDAMATFA), and 
PDDA. On Table  4 the present results for antimicrobial 
activity are compared with those previously obtained by 
Timofeeva and coworkers [39]. Table 4 clarifies important 
aspects of the structure–activity relationship for PDDA 
and derivatives which varies in accordance to polymer 
molecular weight and hydrophobic-hydrophilic balance. 
The antimicrobial activity against Gram-negative bacteria 
increases with molecular weight and with the hydropho-
bic-hydrophilic balance of the cationic polymers. How-
ever, for Gram-positive bacteria or fungus these effects do 
not occur for all strains tested. In particular, against the 
fungus no effect of the molecular weight or the hydropho-
bic-hydrophilic balance are apparent. The fungus is very 
sensitive to all PDDA derivatives.
Conclusions
Several novel antimicrobial polymers are appearing in 
the literature, which require formulation to become 
PMMA NP core
PMMA/PDDA NPs
PDDA NP shell
Fig. 8 Schematic representation of the PMMA/PDDA NPs structure. The core–shell nature of the cationic PMMA/PDDA NPs at low ionic strength
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biocompatible and less toxic against mammalian cells. A 
subtle balance between antimicrobial activity and toxicity 
against the mammalian cells must be achieved in novel 
formulations for antimicrobials. The novel formulations 
for antimicrobial polymers must ensure biocompatibil-
ity without hampering the antimicrobial activity. In this 
work, the physical immobilization of the antimicrobial 
polymer PDDA in biocompatible PMMA NPs preserves 
the PDDA activity against E. coli and its low toxic-
ity against red blood cells, but the same does not occur 
against S. aureus and C. albicans due to their different 
cell walls that are less sensitive to cationic nanoparticles 
and very sensitive to the free antimicrobial polymer.
Methods
Chemicals
MMA, AIBN, NaCl and PDDA (20 weight  % in water; 
100,000–200,000 of molecular weight) were from Sigma-
Aldrich (Steinheim, Germany) and were used without 
further purification. The syntheses were performed in 
a 1  mM NaCl solution prepared with Milli-Q water. 
The dispersions obtained by emulsion polymerization 
Fig. 9 The chemical structure of three PDDA derivatives with increasing hydrophobic‑hydrophilic balance. From left to right are PDAATFA, 
PDAMATFA and PDDA
Table 4 The dependence of  antimicrobial activity on  the microorganism, Mw and  hydrophobic–hydrophilic balance 
of the cationic polymer
MMC, in mg mL−1 , for PDAATFA, PDAMATFA and PDDA against bacteria and fungi. The Mw value is given in kDa. The hydrophobic–hydrophilic balance increases with 
methylation of the nitrogen. PDAATFA, PDAMATFA and PDDA have none, one or two methyl groups attached to the nitrogen, respectively
a The MMC is the minimal concentration for the total inhibition of microorganism growth
b The minimal concentration for reduction of CFU counting to one
Microorganism MMC (µg/mL) References
PDAATFA PDAMATFA, Mw (kDa) PDDA
24 62 24 55 150
E. coli ATCC 25922 125 ± 7.5a 15 ± 1.8a 62 ± 5.0a 7 ± 1.0a [39]
5 This work
P. aeruginosa ATCC 9027 125 ± 7.5a 31 ± 3.1a [39]
P. aeruginosa MDR 1.5b [35]
K. pneumoniae ATCC 13883 15 ± 1.8a 62 ± 5.0a [39]
K. pneumoniae KPC+ 0.9b [35]
S. aureus ATCC 6538 P 31 ± 3.1a 1.5 ± 0.3a 62 ± 5.0a 7 ± 1.0a [39]
S. aureus ATCC 29213 >500b This work
MRSA 5.0b [35]
C. albicans ATCC 865‑653 3.5 ± 0.6a 1.5 ± 0.3a 3.5 ± 0.3a 3.5 ± 0.6a [39]
C. albicans ATCC 90028 5 This work
C. albicans fluconazole resistant 0.8b [35]
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were purified by dialysis using cellulose acetate mem-
branes (Sigma-Aldrich) with molecular weight cut-off in 
the range of 12,400  g/mol. Difco Mueller–Hinton Agar 
(MHA) was from Becton–Dickinson and Co (Sparks, MD, 
USA) and Sabouraud 4  % Glucose Agar (SA) was from 
Fluka Analytical (Sigma-Aldrich, Steinheim, Germany).
Preparation of PMMA/PDDA nanoparticles by emulsion 
polymerization
Polymerization reactions were carried out at 85 °C under 
reflux for 2 h using 100 mL of aqueous solutions of NaCl 
1 mM and PDDA over a range of PDDA concentrations 
at 0.56 or 1.32  M MMA as shown on Table  1. A weak 
flow of N2 was applied to the solution during 30 min both 
before and after adding 6 or 14 mL of MMA containing 
0.036 g of AIBN initiator. After 2 h, the reaction mixture 
was removed from the dry bath and allowed to reach the 
room temperature (25 °C). The dispersions thus obtained 
were purified by dialysis against Milli-Q water until the 
conductivity of dialysis water achieved 5 µs/cm.
Particle sizing and zeta‑potential analysis of PMMA/PDDA 
dispersions
Size distributions, Dz, ζ and P were obtained by DLS 
using a Zeta Plus–Zeta Potential Analyzer (Brookhaven 
Instruments Corporation, Holtsville, NY, USA) equipped 
with a laser of 677  nm with measurements at 90°. P of 
the dispersions was determined by DLS following well 
defined mathematic equations [40]. Dz values were 
obtained from the log normal distribution of the light 
-scattered intensity curve against the diameter. ζ values 
were determined from the electrophoretic mobility (μ) 
and Smolukowski equation ζ = μη/ε, where η and ε are 
the viscosity and the dielectric constant of the medium, 
respectively. Samples were diluted 1:30 with a 1  mM 
NaCl water solution for performing the measurements at 
(25 ± 1) °C.
Determination of PMMA molecular weight and particles 
morphology in PMMA/PDDA dispersions
The PMMA/PDDA dispersions were lyophilized in order 
to obtain dry particles. The conversion of monomer 
into polymer and the solid contents were determined by 
gravimetric measurements. The degree of polymerization 
was determined from the mean molecular weight divided 
by the monomer molecular weight (100, 12 g/mol). Mw, 
pondered molecular weight (Mn) and the polydispersity 
index (PDI) equal to Mw/Mn were obtained by SEC using 
a Shimadzu HPLC/SEC class-VP equipped with two col-
umns Viscogel™ (I-MBMMW 3078 and I-Oligo 3078, 
30 cm × 8 mm each, Viscotek) with exclusion limits of 20 
and 10 kDa, respectively, connected to a refractive index 
differential detector Shimadzu RID 10A. The solvent was 
chloroform with a flow of 1 mL/min. The SEC system was 
calibrated using seven polystyrene standards of low PDI 
(Aldrich/Waters; Mw =  820, 2460, 5120, 13,200, 29,300, 
47,500 and 216,000  g/mol) and toluene was employed 
to identify the exclusion limit (conventional calibra-
tion). Samples of lyophilized PMMA/PDDA dispersions 
(10  ±  1  mg/mL) were firstly solubilized in chloroform 
with precipitation of the cationic PDDA and SEC analy-
ses of the solubilized PMMA in the supernatant.
Elemental analyses were performed in a Perkin -Elmer 
CHN 200 equipment allowing the quantitative determi-
nation of carbon, hydrogen, and nitrogen in the lyophi-
lized dispersions.
SEM was performed in a Jeol JSM-7401F equipment. 
2μL of each dispersion was placed on silicon wafers and 
dried in a desiccator before being covered with a thin 
layer of gold for the SEM visualization. Mean D values 
from the SEM micrographs was also determined using 
the ImageJ software for particle size analysis and shown 
as a mean D ± mean standard deviation.
Determination of the effect of ionic strength on Dz for NPs
The original A3 formulation obtained in pure water after 
dialysis was diluted 1:30 in aqueous NaCl solutions pre-
viously prepared over a range of NaCl concentrations 
(1–100 mM NaCl) and the mean hydrodynamic diameter 
was obtained as described above by dynamic light scat-
tering. Dz values were plotted as a function of the final 
NaCl concentration (Additional file 1).
Organisms and culture conditions
E. coli ATCC (American Type Culture Collection) 25322, 
S. aureus ATCC 29213 and C. albicans ATCC 90028 were 
reactivated from previously frozen stocks kept at −20 °C 
in appropriate storage medium. The bacterial strains 
were plated onto MHA before incubating the plates at 
37 °C/18–24 h. The yeast cells were plated onto SA before 
incubating at 37 °C/48 h. Thereafter, some isolated colo-
nies were transferred to an isotonic 0.264  M d-glucose 
solution, and the turbidity was adjusted to 0.5 of the 
McFarland scale [41]. The 0.264  M d-glucose solution 
was used instead of any culture medium because cati-
onic molecules are inactivated by the relatively high ionic 
strength and also by the negatively charged molecules 
such as aminoacids and polysaccharides. For determina-
tion of cell viability in the presence of NPs, final bacteria 
and fungus cell concentrations in the suspensions were 
ca. 108 and 105 CFU/mL, respectively.
Cell viability assays
Previous dilutions of the NPs over a range of NPs con-
centrations for obtaining the desired range of PDDA con-
centrations in the NPs were performed before interacting 
Page 12 of 13Sanches et al. J Nanobiotechnol  (2015) 13:58 
NPs and microbes. Microorganisms and dispersions 
(0.5 mL of each) interacted for 1 h at 25  °C before plat-
ing 0.1 mL of the diluted mixtures (dilution up to 100,000 
times for bacteria and 1000 times for fungus) on agar in 
duplicate and incubating (24  h/37  °C for bacteria and 
48  h/37  °C for fungus) for CFU counting. Cell viability 
was plotted as the log (CFU/mL) ±  the mean standard 
deviation as a function of PDDA concentration in the 
control for PDDA only or PDDA in NP. The positive con-
trol was performed for mixtures of the microorganism 
suspension with the 0.264  M d-glucose solution. Mini-
mal microbicidal concentration (MMC) is the lowest 
PDDA concentration required for complete killing of the 
microbes and log of cell viability equal to zero.
Hemolysis assays
The defibrinated sheep blood for the hemolysis assay 
was centrifuged and the pelleted for rinsing three times 
in d-Glucose 0.264  M solution before being finally 
resuspended to yield a 1  % red blood cells suspension. 
An aliquot of 0.5  mL of the 1  % erythrocytes suspen-
sion interacted for 1  h with 0.5  mL of NPs dispersion 
before centrifuging (3  min/3000 rpm) and determining 
the supernatant absorbance at 514 nm (A). The negative 
control (AC−) was 0.5  mL 1  % erythrocytes suspension 
added of 0.5  mL 0.264  M d-glucose solution. The posi-
tive control (AC+) was 0.5 mL 1 % erythrocytes suspen-
sion added of 0.5 mL 1 % Triton-X in 0.264 M d-glucose 
solution. The percentile of hemolysis (%H) induced by 
PDDA alone or in NPs was obtained from %H =  100× 
(A − AC−)/AC+.
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